173 related articles for article (PubMed ID: 36627528)
1. Tear levels of IL-7, IL-1α, and IL-1β may differentiate between IgG4-related disease and Sjögren's syndrome.
Martín-Nares E; Hernández-Molina G; Lima G; Hernández-Ramírez DF; Chan-Campos I; Saavedra-González V; Llorente L
Clin Rheumatol; 2023 Apr; 42(4):1101-1105. PubMed ID: 36627528
[TBL] [Abstract][Full Text] [Related]
2. Analysis of tear cytokines and clinical correlations in Sjögren syndrome dry eye patients and non-Sjögren syndrome dry eye patients.
Lee SY; Han SJ; Nam SM; Yoon SC; Ahn JM; Kim TI; Kim EK; Seo KY
Am J Ophthalmol; 2013 Aug; 156(2):247-253.e1. PubMed ID: 23752063
[TBL] [Abstract][Full Text] [Related]
3. Altered balance of interleukin-13/interferon-gamma contributes to lacrimal gland destruction and secretory dysfunction in CD25 knockout model of Sjögren's syndrome.
Bian F; Barbosa FL; Corrales RM; Pelegrino FS; Volpe EA; Pflugfelder SC; de Paiva CS
Arthritis Res Ther; 2015 Mar; 17(1):53. PubMed ID: 25889094
[TBL] [Abstract][Full Text] [Related]
4. Pathogenesis of IgG4-related disease. Comparison with Sjögren's syndrome.
Tsuboi H; Honda F; Takahashi H; Ono Y; Abe S; Kondo Y; Matsumoto I; Sumida T
Mod Rheumatol; 2020 Jan; 30(1):7-16. PubMed ID: 31425659
[TBL] [Abstract][Full Text] [Related]
5. Altered cytokine balance in the tear fluid and conjunctiva of patients with Sjögren's syndrome keratoconjunctivitis sicca.
Pflugfelder SC; Jones D; Ji Z; Afonso A; Monroy D
Curr Eye Res; 1999 Sep; 19(3):201-11. PubMed ID: 10487957
[TBL] [Abstract][Full Text] [Related]
6. Differential Diagnosis of Sjögren Versus Non-Sjögren Dry Eye Through Tear Film Biomarkers.
Akpek EK; Wu HY; Karakus S; Zhang Q; Masli S
Cornea; 2020 Aug; 39(8):991-997. PubMed ID: 32195754
[TBL] [Abstract][Full Text] [Related]
7. Chemokine tear levels in primary Sjögren's syndrome and their relationship with symptoms.
Hernández-Molina G; Ruiz-Quintero N; Lima G; Hernández-Ramírez D; Llorente-Chávez A; Saavedra-González V; Jiménez-Soto R; Llorente L
Int Ophthalmol; 2022 Aug; 42(8):2355-2361. PubMed ID: 35059930
[TBL] [Abstract][Full Text] [Related]
8. Characterization and Comparison of Patient Subgroups Suspicious for IgG4-Related Disease and Malignant Lymphoma in Patients Followed-up for Sjögren's Syndrome.
Szántó A; Szabó K; Nagy G; Molnár C; Zeher M
Pathol Oncol Res; 2016 Jul; 22(3):579-85. PubMed ID: 26786867
[TBL] [Abstract][Full Text] [Related]
9. Distinct metabolic biomarkers to distinguish IgG4-related disease from Sjogren's syndrome and pancreatic cancer and predict disease prognosis.
Yan S; Peng Y; Wu Z; Cheng L; Li H; Xu H; Huang Y; Zhang W; Li Y
BMC Med; 2022 Dec; 20(1):497. PubMed ID: 36575511
[TBL] [Abstract][Full Text] [Related]
10. A cohort study of T helper 17 cell-related cytokine levels in tear samples of systemic lupus erythematosus and Sjögren's syndrome patients with dry eye disease.
Peng X; Lu Y; Wei J; Lin T; Lu Q; Liu Q; Ting WJ
Clin Exp Rheumatol; 2021; 39 Suppl 133(6):159-165. PubMed ID: 34596026
[TBL] [Abstract][Full Text] [Related]
11. Correlation between Tear Osmolarity and Other Ocular Surface Parameters in Primary Sjögren's Syndrome.
Kim M; Kim HS; Na KS
Korean J Ophthalmol; 2017 Feb; 31(1):25-31. PubMed ID: 28243020
[TBL] [Abstract][Full Text] [Related]
12. Tear cathepsin S as a candidate biomarker for Sjögren's syndrome.
Hamm-Alvarez SF; Janga SR; Edman MC; Madrigal S; Shah M; Frousiakis SE; Renduchintala K; Zhu J; Bricel S; Silka K; Bach D; Heur M; Christianakis S; Arkfeld DG; Irvine J; Mack WJ; Stohl W
Arthritis Rheumatol; 2014 Jul; 66(7):1872-81. PubMed ID: 24644101
[TBL] [Abstract][Full Text] [Related]
13. Novel Cytokine Multiplex Assay for Tear Fluid Analysis in Sjogren's Syndrome.
Willems B; Tong L; Minh TDT; Pham ND; Nguyen XH; Zumbansen M
Ocul Immunol Inflamm; 2021 Nov; 29(7-8):1639-1644. PubMed ID: 32657632
[No Abstract] [Full Text] [Related]
14. Discovery and Verification of Sjögren's Syndrome Protein Biomarkers in Tears by Targeted LC-MRM.
Lépine M; Robert MC; Sleno L
J Proteome Res; 2024 Jun; 23(6):2219-2229. PubMed ID: 38682820
[TBL] [Abstract][Full Text] [Related]
15. Time course of cytokine upregulation in the lacrimal gland and presence of autoantibodies in a predisposed mouse model of Sjögren's Syndrome: the influence of sex hormones and genetic background.
Czerwinski S; Mostafa S; Rowan VS; Azzarolo AM
Exp Eye Res; 2014 Nov; 128():15-22. PubMed ID: 25218176
[TBL] [Abstract][Full Text] [Related]
16. Rapamycin Eye Drops Suppress Lacrimal Gland Inflammation In a Murine Model of Sjögren's Syndrome.
Shah M; Edman MC; Reddy Janga S; Yarber F; Meng Z; Klinngam W; Bushman J; Ma T; Liu S; Louie S; Mehta A; Ding C; MacKay JA; Hamm-Alvarez SF
Invest Ophthalmol Vis Sci; 2017 Jan; 58(1):372-385. PubMed ID: 28122086
[TBL] [Abstract][Full Text] [Related]
17. Biomarkers of ocular allergy and dry eye disease.
Zemba M; Ionescu MA; Pîrvulescu RA; Dumitrescu OM; Daniel-Constantin B; Radu M; Stamate AC; Istrate S
Rom J Ophthalmol; 2023; 67(3):250-259. PubMed ID: 37876509
[TBL] [Abstract][Full Text] [Related]
18. Innate Immune Signaling Induces IL-7 Production, Early Inflammatory Responses, and Sjögren's-Like Dacryoadenitis in C57BL/6 Mice.
Zhou J; Jin JO; Du J; Yu Q
Invest Ophthalmol Vis Sci; 2015 Dec; 56(13):7831-8. PubMed ID: 26658504
[TBL] [Abstract][Full Text] [Related]
19. Fluorescence-based reagent and spectrum-based optical reader for lactoferrin detection in tears: differentiating Sjögren's syndrome from non-Sjögren's dry eye syndrome.
Tsai CY; Hong C; Hsu MY; Lai TT; Huang CW; Lu CY; Chen WL; Cheng CM
Sci Rep; 2024 Jun; 14(1):14505. PubMed ID: 38914667
[TBL] [Abstract][Full Text] [Related]
20. [The evaluation of chosen cytokines in induction of ocular changes in Sjögren's syndrome of dry eye].
Zywalewska-Górna N; Mrugacz M; Bakunowicz-Lazarczyk A
Klin Oczna; 2007; 109(10-12):435-7. PubMed ID: 18488390
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
